Concepedia

Blessing Ja

BJ

Statistics

Publications

12

Citations

542

H-Index

12

Active since

1978

Affiliations

Rush University Medical Center(Current)

Blessing Ja is an author at Rush University Medical Center specializing in oncology, medicine, and chemotherapy.

Publications per year

1978–1987

12

Publications

12

Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.

Thigpen Jt, Buchsbaum Hj, Charles E. Mangan et al. · PubMed · 1979 · 151 citations

Medicine, Oncology, Pharmacotherapy +16

Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

Thigpen Jt, Blessing Ja, Orr Jw et al. · PubMed · 1986 · 88 citations

Medicine, Gynecology, Oncology +14

Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.

Slayton Re, Creasman Wt, Petty W et al. · PubMed · 1980 · 50 citations

Medicine, Gynecology, Oncology +11

Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.

Wallace Hj, Hreshchyshyn Mm, Wilbanks Gd et al. · PubMed · 1978 · 47 citations

Medicine, Oncology, Pharmacology +15

Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.

M Slavík, Petty Wm, Blessing Ja et al. · PubMed · 1984 · 37 citations

Medicine, Gynecology, Oncology +9

1–5 of 12